Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard G Birnbaum

Showing results (1-10 of 112) with videos related to

Pageof 12
Sort By:
Pharmacoeconomics|September 14, 2010
Introducing perspectives on comparative effectiveness researchHoward G Birnbaum, Paul E Greenberg
Expert Opinion on Pharmacotherapy|March 30, 2005
The economic burden of depression in the US: societal and patient perspectivesPaul E Greenberg, Howard G Birnbaum
Pharmacoeconomics|September 14, 2010
Perspectives on comparative effectiveness research: views from diverse constituenciesDave Nellesen, Howard G Birnbaum, Paul E Greenberg
Journal of Pain & Palliative Care Pharmacotherapy|May 28, 2010
Volume of prescription opioids used nonmedically in the United StatesNathaniel P Katz, Howard G Birnbaum, Adam Castor
Journal of Affective Disorders|March 21, 2003
The economics of women and depression: an employer's perspectiveHoward G Birnbaum, Stephanie A Leong, Paul E Greenberg
Applied Health Economics and Health Policy|June 30, 2009
Development of a budget-impact model to quantify potential cost savings from prescription opioids designed to deter abuse or ease of extractionAlan G White, Howard G Birnbaum, Dov B Rothman, et al.
Chest|June 11, 2004
Treatment costs of community-acquired pneumonia in an employed populationGene L Colice, Melissa A Morley, Carl Asche, et al.
Chest|August 13, 2002
Economic burden of respiratory infections in an employed populationHoward G Birnbaum, Melissa Morley, Paul E Greenberg, et al.
Journal of Occupational and Environmental Medicine|December 29, 2010
Prevalence rates and costs of metabolic syndrome and associated risk factors using employees' integrated laboratory data and health care claimsHoward G Birnbaum, Miles E Mattson, Sara Kashima, et al.
Pharmacoeconomics|March 3, 2012
Changes in utilization and costs for patients with rheumatoid arthritis, 1997 to 2006Howard G Birnbaum, Crystal Pike, Ritesh Banerjee, et al.
Pageof 12

Showing results (1-10 of 112) with videos related to

Sort By:
Pageof 12
Pharmacoeconomics|September 14, 2010
Introducing perspectives on comparative effectiveness researchHoward G Birnbaum, Paul E Greenberg
Expert Opinion on Pharmacotherapy|March 30, 2005
The economic burden of depression in the US: societal and patient perspectivesPaul E Greenberg, Howard G Birnbaum
Pharmacoeconomics|September 14, 2010
Perspectives on comparative effectiveness research: views from diverse constituenciesDave Nellesen, Howard G Birnbaum, Paul E Greenberg
Journal of Pain & Palliative Care Pharmacotherapy|May 28, 2010
Volume of prescription opioids used nonmedically in the United StatesNathaniel P Katz, Howard G Birnbaum, Adam Castor
Journal of Affective Disorders|March 21, 2003
The economics of women and depression: an employer's perspectiveHoward G Birnbaum, Stephanie A Leong, Paul E Greenberg
Applied Health Economics and Health Policy|June 30, 2009
Development of a budget-impact model to quantify potential cost savings from prescription opioids designed to deter abuse or ease of extractionAlan G White, Howard G Birnbaum, Dov B Rothman, et al.
Chest|June 11, 2004
Treatment costs of community-acquired pneumonia in an employed populationGene L Colice, Melissa A Morley, Carl Asche, et al.
Chest|August 13, 2002
Economic burden of respiratory infections in an employed populationHoward G Birnbaum, Melissa Morley, Paul E Greenberg, et al.
Journal of Occupational and Environmental Medicine|December 29, 2010
Prevalence rates and costs of metabolic syndrome and associated risk factors using employees' integrated laboratory data and health care claimsHoward G Birnbaum, Miles E Mattson, Sara Kashima, et al.
Pharmacoeconomics|March 3, 2012
Changes in utilization and costs for patients with rheumatoid arthritis, 1997 to 2006Howard G Birnbaum, Crystal Pike, Ritesh Banerjee, et al.
Pageof 12